Biochem/physiol Actions
BAY-364 (BAY-299N) is structurally similar to selective BRD1/TAF1 inhibitor BAY-299 and serves as inactive control. BAY-364 is inactive against BRD1 and exhibit moderate activity against TAF1 (3 µM). For full characterization details of the active probe, please visit the BAY-299 probe summary on the Structural Genomics Consortium (SGC) website.BAY-299, the active probe, is available from Sigma. To learn more about and purchase BAY-299, click here.To learn about other SGC chemical probes for protein targets, visit sigma.com/sgc
Features and Benefits
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
BAY-364 is a negative control for BAY-299, an epigenetic chemical probe available through a partnership with the Structural Genomics Consortium (SGC). To learn more and view other SGC epigenetic probes, visit sigma.com/SGC
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: